(NYSE: TFX) Teleflex's forecast annual revenue growth rate of 8.6% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 9.77%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.61%.
Teleflex's revenue in 2026 is $1,992,713,000.On average, 14 Wall Street analysts forecast TFX's revenue for 2026 to be $102,147,498,782, with the lowest TFX revenue forecast at $98,744,055,508, and the highest TFX revenue forecast at $106,611,755,544. On average, 13 Wall Street analysts forecast TFX's revenue for 2027 to be $107,407,365,660, with the lowest TFX revenue forecast at $103,385,114,518, and the highest TFX revenue forecast at $112,799,834,224.
In 2028, TFX is forecast to generate $112,844,034,786 in revenue, with the lowest revenue forecast at $108,556,580,272 and the highest revenue forecast at $118,369,105,036.